Brind.

CIRCA received FDA clearances for new systems, while Darby was appointed CEO and Geist transitioned to COO.

2 reports, 2 independent Updated Aug 12

Gone quiet

Reports: 2
Developments: 2
Repetition: 0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

CIRCA received FDA clearances for new systems, while Darby was appointed CEO and Geist transitioned to COO.

Who's involved

What this event is mainly about

Circa Darby Geist FDA

How it developed

Newest first. Tap a step to see who reported it.

Aug 12Darby raises concerns about the viability of the industry's current financing model.1 source
- canadianminingjournal.com
Jul 24CIRCA secures FDA clearances, appoints Darby as CEO, and Geist joins as COO.1 source
- prnewswire.com

Keep exploring

The entities involved

Circa
UK record label; imprint of Circa Records Ltd.

Nothing else this week.
Darby
cricketer

Nothing else this week.
Geist
Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Aug 12canadianminingjournal.com
Jul 24prnewswire.comCIRCA Scientific Appoints Jack Darby as Chief Executive Officer to Accelerate Commercial Expansion of Cardiovascular Access Portfolio